Literature DB >> 22694354

Hepatitis B virus infection increases the risk of cholangiocarcinoma: a meta-analysis and systematic review.

Min Li1, Jinzheng Li, Peizhi Li, Hongyang Li, Tianyi Su, Rongtao Zhu, Jianping Gong.   

Abstract

BACKGROUND AND AIM: A number of studies have shown that hepatitis virus infections may be associated with cholangiocarcinoma (CC). However, the relationship between hepatitis B virus (HBV) infection and CC, especially intrahepatic cholangiocarcinoma (ICC), is still controversial.
METHODS: Relevant studies were identified by searching PUBMED, EMBASE and Web of Science Datebases up to September 2011. Pooled risk estimates were calculated using a random-effects model. Potential sources of heterogeneity were performed by subgroup analyses. A total of 18 papers were included in this meta-analysis.
RESULTS: The pooled risk estimate of all studies showed a statistically significant increased risk of CC among individuals with HBV infection (rate ratio [RR]: 2.66; 95% confidence interval [CI]: 1.97, 3.60). Compared with those without HBV infection, persons with HBV infection had an increased risk of intra-CC (ICC) (RR: 3.42; 95% CI: 2.46, 43.74), extrahepatic CC (OR: 1.46; 95% CI: 0.98, 2.17), and CC (OR: 2.03; 95% CI: 1.15, 3.56). In a subgroup analysis of HBV infection and risk of ICC, the pooled risk estimate of studies in Asians (RR: 3.63; 95% CI: 2.56, 5.13) was higher than that in non-Asians (RR: 1.93; 95% CI: 0.78, 4.76). A Begg funnel plot and Egger test revealed no evidence for publication bias.
CONCLUSIONS: This meta-analysis shows that HBV is associated with increased risk of CC, especially for ICC. Further investigation is needed to focus on the mechanism by which HBV may be involved in the pathogenesis of CC.
© 2012 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22694354     DOI: 10.1111/j.1440-1746.2012.07207.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  32 in total

1.  Viral hepatitis B and C infections increase the risks of intrahepatic and extrahepatic cholangiocarcinoma: Evidence from a systematic review and meta-analysis.

Authors:  Jie-Hui Tan; Wan-Yan Zhou; Lei Zhou; Rong-Chang Cao; Guo-Wei Zhang
Journal:  Turk J Gastroenterol       Date:  2020-03       Impact factor: 1.852

Review 2.  The treatment of cholangiocarcinoma: a hepatologist's perspective.

Authors:  Kamran Qureshi; Randhir Jesudoss; Abdullah M S Al-Osaimi
Journal:  Curr Gastroenterol Rep       Date:  2014-10

3.  Postresection Outcomes of Combined Hepatocellular Carcinoma-Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

Authors:  Young-In Yoon; Shin Hwang; Young-Joo Lee; Ki-Hun Kim; Chul-Soo Ahn; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Jong-Woo Lee; Seung-Mo Hong; Eun Sil Yu; Sung-Gyu Lee
Journal:  J Gastrointest Surg       Date:  2015-12-01       Impact factor: 3.452

4.  Clinicopathological Features and Post-resection Prognosis of Double Primary Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

Authors:  Dong-Hwan Jung; Shin Hwang; Ki-Hun Kim; Seung-Mo Hong; Young-Joo Lee; Chul-Soo Ahn; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Gil-Chun Park; Eun Sil Yu; Sung-Gyu Lee
Journal:  World J Surg       Date:  2017-03       Impact factor: 3.352

5.  Hepatitis B virus infection, diabetes mellitus, and their synergism for cholangiocarcinoma development: a case-control study in Korea.

Authors:  Ban Seok Lee; Eun-Cheol Park; Seung Woo Park; Chung Mo Nam; Jaehoon Roh
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

6.  Epidemiology and Risk Factors of Cholangiocarcinoma.

Authors:  Martha M Kirstein; Arndt Vogel
Journal:  Visc Med       Date:  2016-12-01

Review 7.  Hepatitis B virus infection and intrahepatic cholangiocarcinoma.

Authors:  Hua-Bang Zhou; Jing-Yi Hu; He-Ping Hu
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

8.  A potential association between exposure to hepatitis B virus and small bowel adenocarcinoma.

Authors:  Ersilia M DeFilippis; Mamta Mehta; Emmy Ludwig
Journal:  J Gastrointest Oncol       Date:  2016-06

9.  Geographic variation of intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and hepatocellular carcinoma in the United States.

Authors:  Sean F Altekruse; Jessica L Petrick; Alicia I Rolin; James E Cuccinelli; Zhaohui Zou; Zaria Tatalovich; Katherine A McGlynn
Journal:  PLoS One       Date:  2015-04-02       Impact factor: 3.240

Review 10.  Targeted Therapy in Biliary Tract Cancers.

Authors:  Amartej Merla; Kenneth G Liu; Lakshmi Rajdev
Journal:  Curr Treat Options Oncol       Date:  2015-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.